Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Spinal-induced Hypotension in PCNL
NCT04891484Phase 1Completed
- Sponsor
- Mansoura University
- Start
- Apr 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ondansetron in hypotension (2 arms), sponsored by Mansoura University. Primary endpoint: The incidence of hypotension during spinal anesthesia for percutaneous nephrolithotomy. Started Apr 2021; status: completed.
02
Drugs
ondansetron
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT04891484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04891484.